Femasys (FEMY) Cash & Equivalents (2020 - 2026)

Femasys (FEMY) has 7 years of Cash & Equivalents data on file, last reported at $5.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 40.99% year-over-year to $5.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (up 40.99% YoY), and the FY2025 full-year result was $9.3 million, up 168.45% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $5.4 million, down from $9.3 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $21.8 million in Q1 2022 and bottomed at $3.2 million in Q2 2025.
• The 5-year median for Cash & Equivalents is $10.2 million (2023), against an average of $11.2 million.
• The widest annual swing landed in 2024, when Cash & Equivalents tumbled 84.11%; it then surged 168.45% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $13.0 million in 2022, then jumped by 67.54% to $21.7 million in 2023, then sank by 84.11% to $3.5 million in 2024, then soared by 168.45% to $9.3 million in 2025, then sank by 41.88% to $5.4 million in 2026.
• The last three Cash & Equivalents figures came in at $5.4 million (Q1 2026), $9.3 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.

Peer Comparison